Neurocrine Biosciences Statistics
Total Valuation
NBIX has a market cap or net worth of $10.56 billion. The enterprise value is $9.98 billion.
| Market Cap | 10.56B |
| Enterprise Value | 9.98B |
Important Dates
The next confirmed earnings date is Monday, May 5, 2025, after market close.
| Earnings Date | May 5, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NBIX has 98.94 million shares outstanding. The number of shares has increased by 2.67% in one year.
| Current Share Class | 98.94M |
| Shares Outstanding | 98.94M |
| Shares Change (YoY) | +2.67% |
| Shares Change (QoQ) | -1.34% |
| Owned by Insiders (%) | 1.09% |
| Owned by Institutions (%) | 98.64% |
| Float | 97.75M |
Valuation Ratios
The trailing PE ratio is 32.44 and the forward PE ratio is 17.54. NBIX's PEG ratio is 1.02.
| PE Ratio | 32.44 |
| Forward PE | 17.54 |
| PS Ratio | 4.55 |
| Forward PS | 3.91 |
| PB Ratio | 4.10 |
| P/TBV Ratio | 4.15 |
| P/FCF Ratio | 18.95 |
| P/OCF Ratio | 17.74 |
| PEG Ratio | 1.02 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.36, with an EV/FCF ratio of 17.91.
| EV / Earnings | 29.24 |
| EV / Sales | 4.24 |
| EV / EBITDA | 16.36 |
| EV / EBIT | 17.12 |
| EV / FCF | 17.91 |
Financial Position
The company has a current ratio of 3.40, with a Debt / Equity ratio of 0.19.
| Current Ratio | 3.40 |
| Quick Ratio | 3.06 |
| Debt / Equity | 0.19 |
| Debt / EBITDA | 0.76 |
| Debt / FCF | 0.89 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 14.16% and return on invested capital (ROIC) is 12.68%.
| Return on Equity (ROE) | 14.16% |
| Return on Assets (ROA) | 10.46% |
| Return on Invested Capital (ROIC) | 12.68% |
| Return on Capital Employed (ROCE) | 18.16% |
| Revenue Per Employee | $1.31M |
| Profits Per Employee | $189,611 |
| Employee Count | 1,800 |
| Asset Turnover | 0.68 |
| Inventory Turnover | 15.99 |
Taxes
In the past 12 months, NBIX has paid $144.70 million in taxes.
| Income Tax | 144.70M |
| Effective Tax Rate | 29.77% |
Stock Price Statistics
The stock price has decreased by -23.20% in the last 52 weeks. The beta is 0.33, so NBIX's price volatility has been lower than the market average.
| Beta (5Y) | 0.33 |
| 52-Week Price Change | -23.20% |
| 50-Day Moving Average | 108.39 |
| 200-Day Moving Average | 126.16 |
| Relative Strength Index (RSI) | 54.68 |
| Average Volume (20 Days) | 1,831,171 |
Short Selling Information
The latest short interest is 3.79 million, so 3.83% of the outstanding shares have been sold short.
| Short Interest | 3.79M |
| Short Previous Month | 3.29M |
| Short % of Shares Out | 3.83% |
| Short % of Float | 3.87% |
| Short Ratio (days to cover) | 3.04 |
Income Statement
In the last 12 months, NBIX had revenue of $2.36 billion and earned $341.30 million in profits. Earnings per share was $3.29.
| Revenue | 2.36B |
| Gross Profit | 1.59B |
| Operating Income | 583.00M |
| Pretax Income | 446.90M |
| Net Income | 341.30M |
| EBITDA | 610.10M |
| EBIT | 583.00M |
| Earnings Per Share (EPS) | $3.29 |
Balance Sheet
The company has $1.08 billion in cash and $495.70 million in debt, giving a net cash position of $580.40 million or $5.87 per share.
| Cash & Cash Equivalents | 1.08B |
| Total Debt | 495.70M |
| Net Cash | 580.40M |
| Net Cash Per Share | $5.87 |
| Equity (Book Value) | 2.59B |
| Book Value Per Share | 26.05 |
| Working Capital | 1.22B |
Cash Flow
In the last 12 months, operating cash flow was $595.40 million and capital expenditures -$38.20 million, giving a free cash flow of $557.20 million.
| Operating Cash Flow | 595.40M |
| Capital Expenditures | -38.20M |
| Free Cash Flow | 557.20M |
| FCF Per Share | $5.63 |
Margins
Gross margin is 67.52%, with operating and profit margins of 24.75% and 14.49%.
| Gross Margin | 67.52% |
| Operating Margin | 24.75% |
| Pretax Margin | 20.63% |
| Profit Margin | 14.49% |
| EBITDA Margin | 25.90% |
| EBIT Margin | 24.75% |
| FCF Margin | 23.66% |
Dividends & Yields
NBIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -2.67% |
| Shareholder Yield | -2.67% |
| Earnings Yield | 3.23% |
| FCF Yield | 5.28% |
Analyst Forecast
The average price target for NBIX is $162.30, which is 52.07% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $162.30 |
| Price Target Difference | 52.07% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 20 |
| Revenue Growth Forecast (5Y) | 13.04% |
| EPS Growth Forecast (5Y) | 38.15% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NBIX has an Altman Z-Score of 8.68 and a Piotroski F-Score of 6.
| Altman Z-Score | 8.68 |
| Piotroski F-Score | 6 |